|
|
|
|
| Top Story |
 |
|
Europe's Cancer Dilemma |
Cancer treatment is an increasing dilemma for health services in Europe as they try to balance patient care against budgetary constraints. Reflector reports
… /Read more/ |
|
|
| Advertisement |
The Changing Biopharma Risk Equation: Written by The Economist Intelligence Unit, this paper incorporates the results of a survey of 254 pharmaceutical executives worldwide and a range of interviews with industry experts, explores global pharmaceutical companies' growth strategies and their plans for managing the associated risks. Sponsored by Merck
 Download this White Paper Now
|
|
| Advertisement |
Read this Front & Center article to see how your Hub can be a Secret Weapon to improve Outcomes.
 Learn more |
|
|
| Advertisement |
Achieving Success in the Biosimilar Market
On Demand
 Learn more |
|
| Advertisement |
Supporting internal and external decision-making through effective MSL activities
On Demand
 Learn more |
|
|
ADVERTISEMENT
|
| Advertisement |
Technology can't replace people- why Patient Support Programs need a personal approach
On Demand
 Learn more |
|
|
| Industry update |
| //Carrie-Lynn Langlais Furr, Ph.D., RAC has been appointed as Vice President of Regulatory Affairs and Program Management at AmpliPhi Biosciences Corporation (San Diego, CA).//Edge Therapeutics (Berkeley Heights, NJ) announced the appointment of Daniel Brennan to the newly created position of Chief Operating Officer.//Inspyr Therapeutics (Westlake Village, CA) appointed Richard Buller, M.D., Ph.D. to its Board of Directors.// |
|
|
